PLAINSBORO, N.J. From leveraging their joint buying power to better deployment of a hard-to-find pediatric liver transplant surgeon, two large healthcare systems in Florida are seeing the benefits of sharing resources on a bigger scale, according to Kavita Patel, MD, of the Brookings Institution, and her co-authors who write in the inaugural issue of The American Journal of Accountable Care.
FOR IMMEDIATE RELEASE DECEMBER 17, 2013
Florida Healthcare Collaborative Offers Road Map For Creating Partnerships to Contain Costs
Brookings’ Dr. Kavita Patel Offers Insights in AJAC
PLAINSBORO, N.J. From leveraging their joint buying power to better deployment of a hard-to-find pediatric liver transplant surgeon, two large healthcare systems in Florida are seeing the benefits of sharing resources on a bigger scale, according to Kavita Patel, MD, of the Brookings Institution, and her co-authors who write in the inaugural issue of The American Journal of Accountable Care.
Patel examines the early returns of a 2010 decision to collaborate in both clincial and governance realms by the University of Florida and Shands, a $2.7 billion enterprise of the University of Florida Academic Health Center and Shands Teaching Hospital and Clinics, and Orlando Health Inc., a $2 billion not-for-profit corporation. The process, which paved the way for a regional accountable care organization (ACO), showed how the these major healthcare providers were able to achieve “millions of dollars” in savings while providing better care for patients. Click here to read the article, “Collaborative Care Before Accountable Care: Achieving Low-Cost, High-Quality Care Through a Regional Collaborative in Florida.”
Geographically, the collaborative stretches from Orlando, in central Florida, all the way to Jacksonsville, on the state’s Atlantic Coast near the Georgia border. That much territory, and access to more than 3 million residents, allowed for collaboration in four major areas: clinical integration, data anlalytics, contracting and operations. As Patel writes, the clinical opportunities were pursued first; other projects came in a second phase.
For each healthcare group, collaboration demanded honesty about its own strengths and weaknesses — and trust. “An expressed intent of these programs is the transparent sharing of data to critically evaluate which system has the best program in order to learn from each other and not duplicate costly services in which regional volumes are low,” Patel writes.
But for patients, the payoffs were worth it. Success stories in clinical areas include:
In the nonclinical areas, the immediate benefits are seen in purchasing savings in both healthcare groups, Patel writes. “Early results of supply chain analysis indicate millions in savings for both organizations,” the article states.
Patel concludes, “We believe that the innovative approach taken by the University of Florida and Shands and Orlando Health has produced not only short-term benefits for both organizations, but also a viable path for transitioning to a more accountable payment and delivery model througha formal ACO contract in the future.”
FOR INFORMATION CONTACT: Nicole Beagin, Associate Editorial Director
(609) 716-7777 x 131
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More